Log in
Enquire now
PEAR Therapeutics

PEAR Therapeutics

A biotechnology and software company offering prescription digital therapeutics.

OverviewStructured DataIssuesContributors

Contents

peartherapeutics.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
‌
Sleep aid
Mobile game
Mobile game
Big data
Big data
Health information technology
Health information technology
Therapeutics
Therapeutics
‌
Digital therapeutics
Mental health
Mental health
...
Location
San Francisco
San Francisco
0
Boston
Boston
0
B2X
B2B
B2B
0
CEO
Corey McCann
Corey McCann
0
Founder
Bill Greene (entrepreneur)
Bill Greene (entrepreneur)
‌
Stephen Kennedy Smith
Corey McCann
Corey McCann
AngelList URL
angel.co/pear-therapeutics
Number of Employees (Ranges)
201 – 5000
Email Address
info@peartherapeutics.com
Phone Number
+61792578480
Number of Employees
3000
Full Address
200 State St Ste 13A, Boston, Massachusetts, 02109, United States0
San Francisco 201 Mission Street San Francisco, CA 941050
200 State st Boston, MA 02109 United States0
200 State St Fl 13, Boston, Massachusetts, 02109, United States0
Investors
Temasek Holdings
Temasek Holdings
Shanda Group
Shanda Group
Sarissa Capital Management
Sarissa Capital Management
TrustBridge Partners
TrustBridge Partners
0
‌
Blue Water Life Science Fund
0
Kirthiga Reddy
Kirthiga Reddy
dRx Capital
dRx Capital
0
‌
Forth Management
...
DUNS Number
079705123
Founded Date
2013
Total Funding Amount (USD)
214,000,000
Latest Funding Round Date
December 2020
Competitors
Biofourmis
Biofourmis
0
RapidOps
RapidOps
0
WellDoc
WellDoc
0
Virta Health
Virta Health
0
Stock Symbol
PEAR0
Exchange
Nasdaq
Nasdaq
0
Glassdoor ID
1486328
Board of Directors
Kirthiga Reddy
Kirthiga Reddy
0
‌
Tim Wicks
0
‌
Paul Mango
0
‌
Shiva Rajaraman
0
‌
Nancy M. Schlichting
0
‌
Alison Bauerlein
0
Corey McCann
Corey McCann
0
CFO
‌
Chris Guiffre
0
Latest Funding Type
Series D
Series D
NAICS Code
51,5180
Patents Assigned (Count)
4
COO
‌
Chris Guiffre
0
Wellfound ID
pear-therapeutics
Country
United States
United States
0
Headquarters
Boston, Massachusetts, United States
Boston, Massachusetts, United States
0

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
80,000,000
Public/Private
Private
SIC Code
73,7370
Wikidata ID
Q41568575

PEAR Therapeutics is a biotechnology and software company offering prescription digital therapeutics (PDTs) that is headquartered in Boston, Massachusetts and was founded in 2013 by Corey McCann, Stephen Smith, and William Greene. Prescription digital therapeutics made by PEAR Therapeutics are software-based treatments for disease in therapeutic areas such as psychiatric and neurological diseases. PEAR Therapeutics was the first company in the world to receive approval from the Food and Drug Administration (FDA) for PDTs claiming to improve the clinical outcomes of disease.

Funding
Series B

On January 2, 2018 PEAR Therapeutics completed their series B funding round with $50 million in funding from Temasek (lead investor), AM Ventures, Arboretum Ventures, JAZZ Venture Partners, Novartis, Singapore-based EDBI, and the Bridge Builder’s Collaborative. The company plans on using the funding to continuing the development and commercialization of their PDT platform. Corey McCann, the CEO, president, and co-founder of PEAR Therapeutics made the following statement regarding on how the company plans on using their series B funding:

This latest financing recognizes the strides we’ve made in proving the clinical utility and commercial viability of prescription digital therapeutics.
Series C

On January 4, 2019 PEAR Therapeutics completed their series C funding round with $64 million in funding from Temasek (lead investor), Novartis, 5AM Ventures, Arboretum Ventures, JAZZ Venture Partners, The Bridge Builders Collaborative, EDBI, Blue Water Life Science Fund, LP., and Trustbridge Partners. The CEO, president, and co-founder of PEAR Therapeutics made the following statement regarding how the company plans on using their series C funding:

Pear now kicks off 2019 with additional capital to bring PDTs to patients. We look forward to establishing PDTs as a widespread modality for directly treating a range of serious diseases.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like PEAR Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.